Artificial intelligence extension of the OSCAR‐IB criteria

Abstract Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big data in neurology is optical coherence tomogra...

Full description

Bibliographic Details
Main Authors: Axel Petzold, Philipp Albrecht, Laura Balcer, Erik Bekkers, Alexander U. Brandt, Peter A. Calabresi, Orla Galvin Deborah, Jennifer S. Graves, Ari Green, Pearse A Keane, Jenny A. Nij Bijvank, Josemir W. Sander, Friedemann Paul, Shiv Saidha, Pablo Villoslada, Siegfried K Wagner, E. Ann Yeh, the IMSVISUAL, ERN‐EYE Consortium
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51320
id doaj-ccdac27211654d478033fb88993a9e04
record_format Article
spelling doaj-ccdac27211654d478033fb88993a9e042021-07-16T05:45:50ZengWileyAnnals of Clinical and Translational Neurology2328-95032021-07-01871528154210.1002/acn3.51320Artificial intelligence extension of the OSCAR‐IB criteriaAxel Petzold0Philipp Albrecht1Laura Balcer2Erik Bekkers3Alexander U. Brandt4Peter A. Calabresi5Orla Galvin Deborah6Jennifer S. Graves7Ari Green8Pearse A Keane9Jenny A. Nij Bijvank10Josemir W. Sander11Friedemann Paul12Shiv Saidha13Pablo Villoslada14Siegfried K Wagner15E. Ann Yeh16the IMSVISUAL, ERN‐EYE ConsortiumMoorfields Eye Hospital City Road, The National Hospital for Neurology and Neurosurgery Queen Square UCL Queen Square Institute of Neurology London UKDepartment of Neurology Medical Faculty Heinrich‐Heine University Düsseldorf GermanyDepartments of Neurology Population Health and Ophthalmology NYU Grossman School of Medicine New York USAAMLAB Amsterdam The NetherlandsDepartment of Neurology University of California Irvine California USADepartment of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USARetina International Dublin IrelandDepartment of Neurosciences UC San Diego California USADepartment of Neurology University of California San Francisco San Francisco California USAMoorfields Eye Hospital City Road, The National Hospital for Neurology and Neurosurgery Queen Square UCL Queen Square Institute of Neurology London UKNeuro‐ophthalmology Expert Center Amsterdam UMC The NetherlandsNIHR UCL Hospitals Biomedical Research Centre UCL Queen Square Institute of Neurology London UKExperimental and Clinical Research Center Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin corporate member of Freie Universität Berlin Humboldt‐Universität zu Berlin, and Berlin Institute of Health GermanyDepartment of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USAInstitut d’Investigacion Biomediques August Pi Sunyer (DIBAPS) and Hospital Clinic University of Barcelona Barcelona SpainMoorfields Eye Hospital City Road, The National Hospital for Neurology and Neurosurgery Queen Square UCL Queen Square Institute of Neurology London UKDivision of Neurology Department of Pediatrics Hospital for Sick Children Division of Neurosciences and Mental Health SickKids Research Institute University of Toronto CanadaAbstract Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big data in neurology is optical coherence tomography (OCT). We highlight that OCT changes observed in the retina, as a window to the brain, are small, requiring rigorous quality control pipelines. There are existing tools for this purpose. Firstly, there are human‐led validated consensus quality control criteria (OSCAR‐IB) for OCT. Secondly, these criteria are embedded into OCT reporting guidelines (APOSTEL). The use of the described annotation of failed OCT scans advances machine learning. This is illustrated through the present review of the advantages and disadvantages of AI‐based applications to OCT data. The neurological conditions reviewed here for the use of big data include Alzheimer disease, stroke, multiple sclerosis (MS), Parkinson disease, and epilepsy. It is noted that while big data is relevant for AI, ownership is complex. For this reason, we also reached out to involve representatives from patient organizations and the public domain in addition to clinical and research centers. The evidence reviewed can be grouped in a five‐point expansion of the OSCAR‐IB criteria to embrace AI (OSCAR‐AI). The review concludes by specific recommendations on how this can be achieved practically and in compliance with existing guidelines.https://doi.org/10.1002/acn3.51320
collection DOAJ
language English
format Article
sources DOAJ
author Axel Petzold
Philipp Albrecht
Laura Balcer
Erik Bekkers
Alexander U. Brandt
Peter A. Calabresi
Orla Galvin Deborah
Jennifer S. Graves
Ari Green
Pearse A Keane
Jenny A. Nij Bijvank
Josemir W. Sander
Friedemann Paul
Shiv Saidha
Pablo Villoslada
Siegfried K Wagner
E. Ann Yeh
the IMSVISUAL, ERN‐EYE Consortium
spellingShingle Axel Petzold
Philipp Albrecht
Laura Balcer
Erik Bekkers
Alexander U. Brandt
Peter A. Calabresi
Orla Galvin Deborah
Jennifer S. Graves
Ari Green
Pearse A Keane
Jenny A. Nij Bijvank
Josemir W. Sander
Friedemann Paul
Shiv Saidha
Pablo Villoslada
Siegfried K Wagner
E. Ann Yeh
the IMSVISUAL, ERN‐EYE Consortium
Artificial intelligence extension of the OSCAR‐IB criteria
Annals of Clinical and Translational Neurology
author_facet Axel Petzold
Philipp Albrecht
Laura Balcer
Erik Bekkers
Alexander U. Brandt
Peter A. Calabresi
Orla Galvin Deborah
Jennifer S. Graves
Ari Green
Pearse A Keane
Jenny A. Nij Bijvank
Josemir W. Sander
Friedemann Paul
Shiv Saidha
Pablo Villoslada
Siegfried K Wagner
E. Ann Yeh
the IMSVISUAL, ERN‐EYE Consortium
author_sort Axel Petzold
title Artificial intelligence extension of the OSCAR‐IB criteria
title_short Artificial intelligence extension of the OSCAR‐IB criteria
title_full Artificial intelligence extension of the OSCAR‐IB criteria
title_fullStr Artificial intelligence extension of the OSCAR‐IB criteria
title_full_unstemmed Artificial intelligence extension of the OSCAR‐IB criteria
title_sort artificial intelligence extension of the oscar‐ib criteria
publisher Wiley
series Annals of Clinical and Translational Neurology
issn 2328-9503
publishDate 2021-07-01
description Abstract Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big data in neurology is optical coherence tomography (OCT). We highlight that OCT changes observed in the retina, as a window to the brain, are small, requiring rigorous quality control pipelines. There are existing tools for this purpose. Firstly, there are human‐led validated consensus quality control criteria (OSCAR‐IB) for OCT. Secondly, these criteria are embedded into OCT reporting guidelines (APOSTEL). The use of the described annotation of failed OCT scans advances machine learning. This is illustrated through the present review of the advantages and disadvantages of AI‐based applications to OCT data. The neurological conditions reviewed here for the use of big data include Alzheimer disease, stroke, multiple sclerosis (MS), Parkinson disease, and epilepsy. It is noted that while big data is relevant for AI, ownership is complex. For this reason, we also reached out to involve representatives from patient organizations and the public domain in addition to clinical and research centers. The evidence reviewed can be grouped in a five‐point expansion of the OSCAR‐IB criteria to embrace AI (OSCAR‐AI). The review concludes by specific recommendations on how this can be achieved practically and in compliance with existing guidelines.
url https://doi.org/10.1002/acn3.51320
work_keys_str_mv AT axelpetzold artificialintelligenceextensionoftheoscaribcriteria
AT philippalbrecht artificialintelligenceextensionoftheoscaribcriteria
AT laurabalcer artificialintelligenceextensionoftheoscaribcriteria
AT erikbekkers artificialintelligenceextensionoftheoscaribcriteria
AT alexanderubrandt artificialintelligenceextensionoftheoscaribcriteria
AT peteracalabresi artificialintelligenceextensionoftheoscaribcriteria
AT orlagalvindeborah artificialintelligenceextensionoftheoscaribcriteria
AT jennifersgraves artificialintelligenceextensionoftheoscaribcriteria
AT arigreen artificialintelligenceextensionoftheoscaribcriteria
AT pearseakeane artificialintelligenceextensionoftheoscaribcriteria
AT jennyanijbijvank artificialintelligenceextensionoftheoscaribcriteria
AT josemirwsander artificialintelligenceextensionoftheoscaribcriteria
AT friedemannpaul artificialintelligenceextensionoftheoscaribcriteria
AT shivsaidha artificialintelligenceextensionoftheoscaribcriteria
AT pablovilloslada artificialintelligenceextensionoftheoscaribcriteria
AT siegfriedkwagner artificialintelligenceextensionoftheoscaribcriteria
AT eannyeh artificialintelligenceextensionoftheoscaribcriteria
AT theimsvisualerneyeconsortium artificialintelligenceextensionoftheoscaribcriteria
_version_ 1721297902860500992